At 2:15 pm on May 8, 2015 the last sale is 2.8 on a total volume of only 8,900 shares. Currently there are 200,000 shares bid for at 2.55 and 500,000 bid for at 2.2. There are 45,000 shares offered up to 3.4. Since the beginning of 2015 approximately 40 million shares traded. That number is pretty close to the entire float in CardioGenics. Utilizing due diligence techniques a shareholder should be able to discover that 50-60 individuals own over 32 million shares. Many of these shareholders significantly increased their positions during this period. IMO, if these shareholders sold any stock it was very minimal. So a logical question would be: Who sold the 40 million shares? The only shares that we know were sold is the 10-12 million that were involved in the financing deals.